Advanced, Refractory Cancer的临床试验
总计57136个结果
-
Duke UniversityUniversity of North Carolina, Chapel Hill完全的
-
Seoul National University HospitalChonbuk National University Hospital; Asan Medical Center; Chonnam National University Hospital; Ulsan University Hospital 和其他合作者完全的
-
ArQule, Inc. (a wholly owned subsidiary of Merck...完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
GERCOR - Multidisciplinary Oncology Cooperative...Merrimack Pharmaceuticals完全的
-
Hanmi Pharmaceutical Company Limited完全的
-
National Cancer Institute (NCI)完全的
-
Massachusetts General HospitalConquer Cancer Foundation招聘中癌症 | 晚期癌症 | 咨询,远程 | Follow-Up Care美国
-
University of Southern CaliforniaNational Cancer Institute (NCI); Auransa, Inc.招聘中晚期恶性实体瘤 | 难治性恶性实体瘤 | 晚期肝细胞癌 | 肝脏转移性恶性肿瘤 | III 期肝细胞癌 AJCC v8 | IV 期肝细胞癌 AJCC v8 | 晚期胆管癌美国
-
National Cancer Institute (NCI)主动,不招人造血和淋巴细胞肿瘤 | 晚期淋巴瘤 | 晚期恶性实体瘤 | 难治性淋巴瘤 | 难治性恶性实体瘤 | 难治性多发性骨髓瘤美国
-
Janssen Research & Development, LLC完全的
-
Merck Sharp & Dohme LLCAriad Pharmaceuticals终止
-
Amsterdam UMC, location VUmc完全的
-
M.D. Anderson Cancer CenterOtsuka Pharmaceutical Development & Commercialization, Inc.完全的
-
Merck Sharp & Dohme LLC完全的Metastatic or Locally Advanced Cancer
-
British Columbia Cancer AgencyBC Cancer Foundation招聘中
-
AbbVie主动,不招人
-
Mayo Clinic完全的
-
Novartis Pharmaceuticals完全的
-
Mirati Therapeutics Inc.完全的
-
Nektar Therapeutics完全的